1334TiPRANDOMISED, MULTICENTRE, PHASE III, OPEN-LABEL STUDY OF ALECTINIB VS CRIZOTINIB IN TREATMENT-NAïVE ANAPLASTIC LYMPHOMA KINASE (ALK)-POSITIVE ADVANCED NSCLC (ALEX STUDY).